Assured Investment Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-36,155
Closed -$582K 375
2019
Q1
$582K Sell
36,155
-16,935
-32% -$274K 0.01% 539
2018
Q4
$777K Buy
53,090
+14,937
+39% +$238K 0.02% 514
2018
Q3
$693K Sell
38,153
-12,494
-25% -$219K 0.01% 667
2018
Q2
$854K Sell
50,647
-3,480
-6% -$65.8K 0.02% 622
2018
Q1
$1.06M Buy
+54,127
New +$1.05M 0.02% 527

Other funds holding HALO

Assured Investment Management's HALO Position: Q2 2019 in Review

Assured Investment Management sold out of Halozyme (HALO) in Q2 2019, closing a stake of 36,155 shares — an estimated $582K sold.

Assured Investment Management first reported a position in HALO in Q1 2018 and held it in 5 quarters. The position peaked at $1.06M in Q1 2018. 202 funds tracked by Wall St. Rank hold HALO as of Q2 2019.

  • Assured Investment Management reported no remaining Halozyme position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 36,155 Halozyme shares in Q2 2019, an estimated $582K.
  • Assured Investment Management first reported a position in Halozyme in Q1 2018 and held it in 5 quarters.
  • Assured Investment Management's Halozyme position peaked at $1.06M in Q1 2018.
  • 202 funds tracked by Wall St. Rank held Halozyme as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.